Prevalence & Testing for KRAS G12C Mutation in NSCLC
​

 

 

FIND KRAS G12C

~13% (1 in 8) of patients with non-squamous NSCLC have the KRAS G12C mutation, yet too many of these patients go unidentified.

Consider testing for all actionable mutations in eligible patients with NSCLC at diagnosis and help Find KRAS G12C.

​

KRAS G12C mutationKRAS G12C mutation

Uncovering
the Unseen 13%

KRAS G12C molecular testingKRAS G12C molecular testing

KRAS G12C
molecular testing

CTA_educational_resourcesCTA_educational_resources

KRAS G12C
educational resources

KRAS, Kirsten rat sarcoma; NSCLC, non-small cell lung cancer.

Reference: Data on file, Amgen; [Analysis of AACR Genie v12].